Movatterモバイル変換


[0]ホーム

URL:


Skip to main content

Advertisement

Springer Nature Link
Log in

Abstract

Pituitary adenomas can cause symptoms by hormonal hypersecretion. Hypersecretion of prolactin (PRL) is responsible for amenorrhea–galactorrhea in women and decreased libido in men, growth hormone (GH) for acromegaly, adrenocorticotropic hormone (ACTH) for Cushing’s disease, and thyroid-stimulating hormone (TSH) for hyperthyroidism. Tumor mass-related effects such as headaches, visual field abnormalities, and depression of hormonal secretion (hypopituitarism) may also be present.

This is a preview of subscription content,log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
¥17,985 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
JPY 3498
Price includes VAT (Japan)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
JPY 12583
Price includes VAT (Japan)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
JPY 15729
Price includes VAT (Japan)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide -see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Similar content being viewed by others

Further Reading

  1. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, et al. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2008;93:2454–62.

    Article PubMed Central CAS PubMed  Google Scholar 

  2. Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, et al. A 12-month phase 3 study of pasireotide in Cushing’s disease. N Engl J Med. 2012;366:914–24.

    Article CAS PubMed  Google Scholar 

  3. Cooper O, Melmed S. Subclinical hyperfunctioning pituitary adenomas: the silent tumors. Best Pract Res Clin Endocrinol Metab. 2012;26:447–60.

    Article PubMed Central CAS PubMed  Google Scholar 

  4. Fleseriu M. Medical management of persistent and recurrent cushing disease. Neurosurg Clin N Am. 2012;23:653–68.

    Article PubMed  Google Scholar 

  5. Fleseriu M. The role of combination medical therapy in acromegaly: hope for the nonresponsive patient. Curr Opin Endocrinol Diabetes Obes. 2013;20:321–9.

    CAS PubMed  Google Scholar 

  6. Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C. Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing’s syndrome. J Clin Endocrinol Metab. 2012;97:2039–49.

    Article CAS PubMed  Google Scholar 

  7. Fleseriu M, Petersenn S. Medical management of Cushing’s disease: what is the future? Pituitary. 2012;15:330–41.

    Article PubMed Central CAS PubMed  Google Scholar 

  8. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly–2011 update. Endocr Pract. 2011;17 Suppl 4:1–44.

    Article PubMed  Google Scholar 

  9. Laws ER, Vance ML, Jane Jr JA. TSH adenomas. Pituitary. 2006;9:313–5.

    Article PubMed  Google Scholar 

  10. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273–88.

    Article CAS PubMed  Google Scholar 

  11. Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, et al. Guidelines for acromegaly management: an update. J Clin Endocrinol Metab. 2009;94:1509–17.

    Article CAS PubMed  Google Scholar 

  12. Molitch ME. Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011;25:885–96.

    Article CAS PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code BTE28, Portland, OR, 97239, USA

    Maria Fleseriu M.D., F.A.C.E.

  2. Department of Neurological Surgery, Oregon Health & Science University, 3303 SW Bond Ave, Mail Code CH8N, Portland, OR, 97239, USA

    Maria Fleseriu M.D., F.A.C.E.

  3. OHSU Northwest Pituitary Center, 3303 SW Bond Ave, Mail Code CH8N, Portland, OR, 97239, USA

    Maria Fleseriu M.D., F.A.C.E.

Authors
  1. Maria Fleseriu M.D., F.A.C.E.

Corresponding author

Correspondence toMaria Fleseriu M.D., F.A.C.E..

Editor information

Editors and Affiliations

  1. Div. Endocrinology, Diabetes & Bone Disease, Mount Sinai School of Medicine Dept. Medicine, New York, New York, USA

    Terry F. Davies

Rights and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fleseriu, M. (2015). Introduction. In: Davies, T. (eds) A Case-Based Guide to Clinical Endocrinology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2059-4_1

Download citation

Publish with us

Access this chapter

Subscribe and save

Springer+ Basic
¥17,985 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
JPY 3498
Price includes VAT (Japan)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
JPY 12583
Price includes VAT (Japan)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
JPY 15729
Price includes VAT (Japan)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide -see info

Tax calculation will be finalised at checkout

Purchases are for personal use only


[8]ページ先頭

©2009-2025 Movatter.jp